Breakthrough Therapy Designation granted based on key positive data from the Phase 2b (RIZE) study and current unmet medical need in congenital ...

GSK plc (GSK, GSK.L) said that the U.S. Food and Drug Administration has granted Breakthrough Therapy Designation for GSK5764227, its ...

Significant advancements in lung cancer treatment were seen throughout 2024, from new drug approvals to promising clinical ...

A groundbreaking therapy first introduced by Northwestern University researchers in 2021 has shown promise in regenerating ...

The FDA has granted priority review to an NDA for taletrectinib in the treatment of advanced ROS1-positive non–small cell ...

On December 20, 2024, the FDA granted accelerated approval to the combination of encorafenib (Braftovi), cetuximab (Erbitux), ...

all in one place with Analyst Top Stocks Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter CSPC Pharmaceutical Group’s breakthrough therapy, SYS6010 ...

Researchers at Children's Hospital of Philadelphia (CHOP) and the University of Pennsylvania Perelman School of Medicine ...

Moderna/Merck partnership and its potential in personalised cancer therapies are good opportunities for long-term investors.

IIT-G and Bose Institute develop advanced injectable hydrogel for precise cancer treatment, minimizing side effects on ...

Navi Mumbai: In a medical breakthrough at Kokilaben Dhirubhai Ambani Hospital, Navi Mumbai, a 39-year-old Rijesh Nair, a ...